TATI - Tübingen Ageing and Tumour Immunology Group
The Tübingen Ageing and Tumour Immunology Group (TATI) conducts research in human immunosenescence, vaccination, tumor immunity, immunotherapy, Alzheimer disease, longevity, immunity and aging. Our expertise is in polychromatic flow cytometry, T cell cloning, confocal microscopy, proteomics, signal transduction, hypoxia, antigen identification, immune monitoring, cancer vaccination, influenza vaccination.
Feinstein L, Douglas CE, Stebbins RC, Pawelec G, Simanek AM, Aiello AE.
Does cytomegalovirus infection contribute to socioeconomic disparities in all-cause mortality?
Mech Ageing Dev. 2016 Sep;158:53-61. [Epub 2016 Jun 4]
Wistuba-Hamprecht K, Martens A, Haehnel K, Geukes Foppen M, Yuan J, Postow MA, Wong P, Romano E, Khammari A, Dreno B, Capone M, Ascierto PA, Demuth I, Steinhagen-Thiessen E, Larbi A, Schilling B, Schadendorf D, Wolchok JD, Blank CU, Pawelec G, Garbe C, Weide B.
Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab.
Eur J Cancer. 2016 Jul 8;64:116-126. [Epub ahead of print]
Tan CT, Wistuba-Hamprecht K, Xu W, Nyunt MS, Vasudev A, Lee BT, Pawelec G, Puan KJ, Rotzschke O, Ng TP, Larbi A.
Vδ2+ and a/ß T cells show divergent trajectories during human aging.
Oncotarget. 2016 Jun 15. [Epub ahead of print]
Fulop T, Witkowski JM, Le Page A, Fortin C, Pawelec G, Larbi A.
Intracellular signaling pathways: Targets to reverse immunosenescence.
Clin Exp Immunol. 2016 Jul 1. [Epub ahead of print]
Shipp C, Speigl L, Janssen N, Martens A, Pawelec G.
A clinical and biological perspective of human myeloid-derived suppressor cells in cancer.
Cell Mol Life Sci. 2016 May 28. [Epub ahead of print]
There is a complete list of the publication since 2012 of the TATI Group on the website.
Recent and Future Activities
Aug 2, 2016: Kilian Wistuba-Hamprecht after the defence of his thesis.
Prof. Pawelec put the hat on Kilian, while Prof. Rammensee was looking on with friends and colleagues.
Jun 16-19, 2016: Graham Pawelec was a speaker at the Regulatory Myeloid Suppressor Cells Conference in in Philadelphia, PA (USA).
April 1, 2016: G. Pawelec became at visiting professor
in the Division of Cancer Studies, Faculty of Life Sciences and Medicine, King’s College London, UK.
March 3, 2016: G. Pawelec: "Immunosenescence and Cancer: is there an 'Immune Risk Profile' in cancer and ageing?"
A lecture at the Manchester Immunology Group, invited by Prof. M. Exley, Manchester, UK.
March 2016: Fakhri Hassouneh, PhD student, from Cordoba, Spain, is visiting scientist
on a DAAD grant working on the role of Cytomegalovirus in immunosenescence.
Feb 9-11, 2016: G. Pawelec: "Immunity and Ageing: causes and consequences of immunosenescence in humans."
A talk at the international summit “Ageing 2016” in London, UK:
Jan 29, 2016: G. Pawelec: "The Clinical Impact of Immunosenescence on Kidney Transplantation."
Lecture at the 16th Canadian Kidney Transplant Forum, invited by Prof. J. Shapiro. Montreal, CA.
G. Pawelec will be attending the following meetings in 2016:
(last update August 9, 2016)
10.-12.8. Sudbury, Ontario (presentations on cancer and ageing at the HSNRI)
11.-15.9. Winchester (PIVAC 16, Co-organiser)
15.-18.9. Nottingham (Visiting Professor lecture)
22.-25.9. Warsaw (speaking at ECB10 meeting The Future of Ageing)
25.-28.9. Cavtat, Dubrovnik (speaking at the Cell Fate Diversity in Aging meeting)
12.-16.10. Siena (NIBIT)
17.-19.10. Montreal (speaking at Biology of Aging: Paving the Way for Healthy Aging)
20.-25.10. Boston (AACR Tumor Immunology meeting)
8.-13.11. National Harbor (Organising a session at SITC)
15.-21.11. New Orleans (presenting in a Symposium at the GSA)
29.11.-1.12. Naples (presenting at Immunotherapy Bridge)
5.-10.12. Liverpool (organising a session at BSI/Dutch Immunol Soc meeting)
14.-18.12. Athens (speaking at Advances in Cancer Immunology and Immunotherapy)
G. Pawelec will be attending the following meetings in 2017:
(last update August 9, 2016)
22.-26.2. Orlando (attending ASCO-SITC joint meeting)
1.-5.4. Washington DC (attending AACR Annual Meeting)
24.-27.4. Prague (speaking at CITIM)
28.-29.4. Rome (speaking at Hematologic Diseases in the Elderly)
4.-6.5. Barcelona (speaking at the EHA meeting)
12.-16.5. Washington DC (attending the AAI Annual Congress)
9.-12.6. New York (attending the AAA Annual Congress)
12.-13.6. Chicago (co-organising the FOCIS Satellite Symposium on Immunity and Aging)
14.-17.6. Chicago (attending FOCIS)
23.-27.7. San Francisco (co-organising a session at the IAGG Conference)